Drug Research
NewBiologix Launches with $50M to Advance Novel Technology Platform
NewBiologix SA launched as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. The launch also includes the completion of a custom built 19,000...
Drug Research
Cellular Origins, ScaleReady Partner to Improve Cell Therapy Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), entered into a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf that brings together...
Drug Research
Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge
Ascend Gene & Cell Therapies, a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, announces that it has launched as a facilitator for gene therapy companies to help...
Drug Research
nVentic report reveals fast-growing manufacturer inventories fail to prevent medicine shortages
nVentic, the inventory optimization specialist, has today launched its 2023 Big Pharma Inventory Benchmarking Report. The report, which analyses the published corporate reports of 28 major pharmaceutical manufacturers, including Merck, AstraZeneca and Pfizer, is an annual look at the...
News
Connected Drug Delivery Devices Boost Healthcare Efficiency
The market for connected drug delivery devices is anticipated to witness a growth rate of almost 23.4% every year from 2022 to 2030. The value of the category is expected to touch $25.6 billion by 2030.
This quick expansion happens...
Drug Research
Advancement In Process Control With New PEACE Algorithm
Researchers have gone on to develop a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can go ahead with the extraction of the particle size distribution (PSD) of a pharmaceutical powder surface from its laser spot. The process provides...
IT & Data Management
AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs
Adherence specialists AARDEX Group are proud to announce its partnership with other industry leaders on DiMe’s new Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework project.
Organizations are taking digital clinical measures and products to scale, meaning digital...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read